Emerging markets offer new trial advantages, but navigating the diverse regulatory standards can be challenging. Quintiles can help.

Watch the webcast

Australia and New Zealand

Since 1993, Quintiles Australia and New Zealand have provided fully integrated services for Phase II-IV clinical studies to the pharmaceutical industry. These locations are part of our infrastructure that enables the transfer of best practices around the globe.

Read more about: